Mindstrong Health Foundation raised $14 million aimed at supporting the platform of diagnosis and neuropsychiatric treatment, reports PatientDaily.com. The Al-powered platform of Mindstrong is designed in a manner which it configures interaction patterns on smartphones to the brains objective measures. The aim of this company is to provide progressive cognition and mood digitized bio-markers which include memory, processing speed, executive function, and attention. Co-founder and President of Mindstrong Heath, Tom Insel, stated that he is excited by the company’s revolution on the typing and scrolling patterns of individuals about specific degrees of cognitive function.
Their new strategies have enabled to create a firm foundation to facilitate better interventions aimed at improving mental health services. Since mental disorders have become a major problem globally, these smartphones will create a solution that will serve the entire globe. This idea was created by ARCH Partners alongside Foresite Capital, who were later joined by Berggruen Holdings, Optum Ventures, and the One Mind fund on Health Impact. According to Market Wired, the Mindstrong team creates understanding on the challenges faced by patients experiencing cognitive impairment.
As modern medicine is founded on an objective measurement, tracking of mental health has been quite a challenge due to the unreliable clinical environment. So as to increase the results on the people suffering from mental disorders, objective measures need to implemented as those of other diseases such as heart problems and diabetes. Therefore, Mindstrong technologies are focused on delivering progressive objective measures on cognition and behavior that has never been achieved before!
Dr. Jim Tananbaum has directed investments in about 21 healthcare companies such as Amerigroup, Amira Pharmaceuticals, and also Jazz Pharmaceuticals. Before working at Mindstrong Health, he founded GelTex Pharmaceuticals which was acquired by Genzyme, and also Theravance. While at GelTex, he served in various positions so as to facilitate the company’s development.
Jim studied at Harvard Medical School where he received an M.D, and later enrolled at Harvard Business School where he studied his Masters in BA. Jim then joined Yale University and attained both a B.S.E.E. & B.S. Jim Tananbaum is a member of both the visiting committee and advisory board at the School of Engineering at Harvard & Yale. Check out his Linked In page for more information.